CBS News, October 27, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, questions why the FDA approves birth control pills that are less safe and have no benefit compared to drugs already on the market.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA says Yaz and Other Next-Generation Birth Control Drugs Appear to Increase Blood Clot Risk
The Republic, October 27, 2011. NRC President, Dr. Diana Zuckerman tells the Republic about problems with the popular birth control Yaz. She questions why you would take Yaz, the more expensive option that can potentially kill you.
Read More »J&J Vaginal Mesh Approved by FDA Based on Similar Device Recalled in 1999
Bloomberg, October 20, 2011. President of the National Research Center for Women & Families Dr. Diana Zuckerman told Bloomberg that the 501(K) FDA approval process has become a gateway for high-risk medical devices such as joint implants and vaginal mesh that can claim a tie to older products.
Read More »Left to Their Own Devices
The Economist, September 10, 2011. Scandals, recalls, stingy customers, anxious regulators—any one of these would traumatise a chief executive. America’s industry for medical devices is suffering from all of them. Omar Ishrak, the new boss of Medtronic, the world’s biggest medical-technology company, recently described the problem succinctly to analysts: “There is a lot of work ahead of us.”
Read More »FDA Advisers Urge Closer Scrutiny of Pelvic Mesh
Associated Press, September 8, 2011. Diana Zuckerman, president of the National Research Center for Women & Families tells the Associated Press about the necessity for studies on pelvic mesh.
Read More »